LOGIN  |  REGISTER
Amneal Pharmaceuticals

LifeSpeak Announces Results of its Annual General Meeting

June 21, 2023 | Last Trade: C$0.37 0.00 0.00

TORONTO, June 21, 2023 /CNW/ - LifeSpeak Inc. ("LifeSpeak" or the "Company") (TSX: LSPK), the leading wholeperson wellbeing solution for employers, health plans and other organizations, today announced the voting results of its annual general meeting of shareholders (the "Meeting") held on June 21, 2023.

All seven nominees listed in the Company's management information circular dated May 8, 2023, were duly elected as Directors of the Company, to hold office until the next annual meeting of the shareholders, with the following results:

Name of Nominee

Votes "for"

Percentage

Votes "Against"

Percentage

Nolan Bederman

27,633,987

98.863 %

317,913

1.137 %

Michael Held

27,633,987

98.863 %

317,913

1.137 %

Sanjiv Samant

27,633,986

98.863 %

317,914

1.137 %

Rajesh Uttamchandani

27,633,987

98.863 %

317,913

1.137 %

Caroline Starner Dadras

27,633,986

98.863 %

317,914

1.137 %

Kevin Smith

27,641,230

98.889 %

310,670

1.111 %

Mario Di Pietro

27,365,737

97.903 %

586,163

2.097 %

The complete biographies of the elected Directors and further details about the Company's corporate governance practices are available at www.LifeSpeak.com.

At the Meeting, MNP LLP was re-appointed as auditor of the Company for the financial year ending on December 31, 2023 and the Directors are authorized to fix their remuneration.

Appointment of Chief Operating Officer

The Company is pleased to announce the appointment of Jason Campana as Chief Operating Officer. In his role as COO, Mr. Campana has responsibility for client teams, company operations, and leading the execution of the Company's strategic growth plan alongside the Executive Leadership Team. Previously, Mr. Campana spent 10+ years as operations leader for Wellbeats, which was acquired by LifeSpeak in 2022. Prior to Wellbeats, Jason spent 8 years as an operations executive in the franchised home services industry.

Mr. Campana graduated from The University of Minnesota's Carlson School of Management with BAs in International Business and Entrepreneurship. He also earned an Executive MBA from The University of St. Thomas.

About LifeSpeak Inc.

LifeSpeak is the leading whole-person-wellbeing platform for employers and other organizations that brings together digital education with human support. Our suite of wellbeing products allows organizations to provide best-in-class content and expertise that scales, meeting each individual wherever they are on their personal wellbeing journeys. As the parent company to LIFT Digital, ALAViDA Health, Torchlight, and Wellbeats, LifeSpeak provides in-depth expertise across mental health, wellness, physical fitness, substance use, and caregiving. With more than 30 years of collective experience working directly with Fortune 500 companies, government agencies, insurance providers, and others across the globe, we understand the complexities of addressing wellbeing within organizations, which is why our digital and data-driven approach provides insights that uncover gaps in wellbeing at the organizational level, ultimately enhancing performance outcomes. To learn more, follow LifeSpeak on LinkedIn (http://www.linkedin.com/company/lifespeak-inc), or visit www.LifeSpeak.com

Chimerix

Stock Quote

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB